X4 Pharmaceuticals Inc (XFOR) Stock Price, Quote, News & History

XFORNASDAQ
$3.58
0.082.29%
At close: Sep 18, 5:00 PM EST
$3.60
0.020.56%
After Hours: 6:01 PM EST

X4 Pharmaceuticals (XFOR) Stock Price, Quote, News & History | Benzinga

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-83.74M
Investing Cash Flow (TTM)
6.43M
Financing Cash Flow (TTM)
233.07M
Free Cash Flow (TTM)
-88.74M
Capital Expenditure (TTM)
-5.00M
Net Change in Cash (TTM)
155.77M

Analyst Trends and Forecast

1
Jun
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$222.22M
PE Ratio (TTM)
2.45
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
22.51
PB Ratio (TTM)
2.23
Earnings Yield % (TTM)
40.86%
Earnings Yield % (FWD)
-25.71%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.57

Company Debt

Total Debt
$76.76M
LT Debt
$76.76M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$195.10M
Debt to Equity
0.50
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.48
Close
$3.58
Volume / Avg.
1.54M / 890.88K
Day Range
$3.48 - $3.64
52 Wk Range
2.80 - 4.83
Market Cap
$356.93M
P/E Ratio
2.45
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
7.27%
Days to Cover
12.84

About

Sector
Health Care
Industry
Biotechnology
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine recep...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy X4 Pharmaceuticals (XFOR) stock?

A

You can purchase shares of X4 Pharmaceuticals (NASDAQ:XFOR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are X4 Pharmaceuticals (XFOR) competitors?

Q

What is the forecast, or price target, for X4 Pharmaceuticals (XFOR) stock?

A

X4 Pharmaceuticals has a consensus price target of $12.71.

Q

What is the current price for X4 Pharmaceuticals (XFOR)?

A

The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $3.6 last updated September 18, 2026 at 6:01 PM EDT.

Q

Does X4 Pharmaceuticals (XFOR) pay a dividend?

A

There are no upcoming dividends for X4 Pharmaceuticals.

Q

When is X4 Pharmaceuticals (NASDAQ:XFOR) reporting earnings?

A

X4 Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is X4 Pharmaceuticals (XFOR) going to split?

A

There is no upcoming split for X4 Pharmaceuticals.

Q

What sector and industry does X4 Pharmaceuticals (XFOR) operate in?

A

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.